Innovation1 Biotech (IVBT) Stock Statistics & Valuation Metrics
Total Valuation
Innovation1 Biotech has a market cap or net worth of $4,494.00. The enterprise value is $183.64B.
- Market Cap
- $4,494.00
- Enterprise Value
- $183.64B
Share Statistics
Innovation1 Biotech has 22,470,240 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 22,470,240
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Innovation1 Biotech’s return on equity (ROE) is 1.75 and return on invested capital (ROIC) is 42.71%.
- Return on Equity (ROE)
- 1.75
- Return on Assets (ROA)
- -78.80
- Return on Invested Capital (ROIC)
- 42.71%
- Return on Capital Employed (ROCE)
- 0.43
- Revenue Per Employee
- 0
- Profits Per Employee
- -5.99M
- Employee Count
- 1
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Innovation1 Biotech is -0.00. Innovation1 Biotech’s PEG ratio is -0.00.
- PE Ratio
- -0.00
- PS Ratio
- 0.00
- PB Ratio
- -0.00
- Price to FCF
- -0.01
- Price to Operating Cash Flow
- -0.01
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Innovation1 Biotech had revenue of 0 and earned -5.99M in profits. Earnings per share was -0.70.
- Revenue
- 0
- Gross Profit
- -52.70K
- Operating Income
- -1.37M
- Pretax Income
- -5.99M
- Net Income
- -5.99M
- EBITDA
- -5.68M
- Earnings Per Share (EPS)
- -0.70
Cash Flow
In the last 12 months, operating cash flow was -515.40K and capital expenditures -5, giving a free cash flow of -515.40K billion.
- Operating Cash Flow
- -515.40K
- Free Cash Flow
- -515.40K
- Free Cash Flow per Share
- -0.03
Dividends & Yields
Innovation1 Biotech pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -13800.62%
- Earnings Yield
- -148335.32%
Stock Price Statistics
- Beta
- -4.96
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.02
- 200-Day Moving Average
- 0.02
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
Innovation1 Biotech as a current ratio of 0.02, with Debt / Equity ratio of -6.68%
- Current Ratio
- 0.02
- Quick Ratio
- 0.02
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- -0.03
- Interest Coverage Ratio
- -5.43
Taxes
In the past 12 months, Innovation1 Biotech has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Innovation1 Biotech EV to EBITDA ratio is -0.03, with an EV/FCF ratio of -0.30.
- EV to Sales
- 0.00
- EV to EBITDA
- -0.03
- EV to Free Cash Flow
- -0.30
- EV to Operating Cash Flow
- -0.30
Balance Sheet
Innovation1 Biotech has $107.53K in cash and marketable securities with $605.06K in debt, giving a net cash position of -$497.54K billion.
- Cash & Marketable Securities
- $107.53K
- Total Debt
- $605.06K
- Net Cash
- -$497.54K
- Net Cash Per Share
- -$0.02
- Tangible Book Value Per Share
- -$0.15
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Innovation1 Biotech is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
